nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—ACHE—Irinotecan—pancreatic cancer	0.144	0.224	CbGbCtD
Mefloquine—CYP19A1—Tamoxifen—pancreatic cancer	0.135	0.211	CbGbCtD
Mefloquine—BCHE—Irinotecan—pancreatic cancer	0.0866	0.135	CbGbCtD
Mefloquine—ABCB1—Tamoxifen—pancreatic cancer	0.0286	0.0446	CbGbCtD
Mefloquine—CYP2D6—Tamoxifen—pancreatic cancer	0.027	0.042	CbGbCtD
Mefloquine—ABCB1—Gemcitabine—pancreatic cancer	0.0247	0.0384	CbGbCtD
Mefloquine—ABCB1—Erlotinib—pancreatic cancer	0.0243	0.0379	CbGbCtD
Mefloquine—CYP2D6—Erlotinib—pancreatic cancer	0.0229	0.0357	CbGbCtD
Mefloquine—ABCB1—Irinotecan—pancreatic cancer	0.022	0.0342	CbGbCtD
Mefloquine—CYP3A4—Tamoxifen—pancreatic cancer	0.0172	0.0267	CbGbCtD
Mefloquine—ABCB1—Docetaxel—pancreatic cancer	0.0161	0.0251	CbGbCtD
Mefloquine—ABCB1—Sunitinib—pancreatic cancer	0.016	0.025	CbGbCtD
Mefloquine—CYP3A4—Erlotinib—pancreatic cancer	0.0146	0.0227	CbGbCtD
Mefloquine—CYP3A4—Irinotecan—pancreatic cancer	0.0132	0.0205	CbGbCtD
Mefloquine—ABCB1—Doxorubicin—pancreatic cancer	0.012	0.0187	CbGbCtD
Mefloquine—CYP2D6—Doxorubicin—pancreatic cancer	0.0113	0.0176	CbGbCtD
Mefloquine—CYP3A4—Docetaxel—pancreatic cancer	0.00965	0.015	CbGbCtD
Mefloquine—CYP3A4—Sunitinib—pancreatic cancer	0.00961	0.015	CbGbCtD
Mefloquine—CYP3A4—Doxorubicin—pancreatic cancer	0.0072	0.0112	CbGbCtD
Mefloquine—HBA2—gall bladder—pancreatic cancer	0.00505	0.291	CbGeAlD
Mefloquine—HBA1—pancreas—pancreatic cancer	0.00253	0.146	CbGeAlD
Mefloquine—HBA2—pancreas—pancreatic cancer	0.00233	0.134	CbGeAlD
Mefloquine—HBA1—digestive system—pancreatic cancer	0.00216	0.125	CbGeAlD
Mefloquine—HBA2—digestive system—pancreatic cancer	0.00199	0.114	CbGeAlD
Mefloquine—ACHE—islet of Langerhans—pancreatic cancer	0.00148	0.0852	CbGeAlD
Mefloquine—BCHE—digestive system—pancreatic cancer	0.000436	0.0251	CbGeAlD
Mefloquine—ABCB1—islet of Langerhans—pancreatic cancer	0.000346	0.02	CbGeAlD
Mefloquine—CYP3A4—digestive system—pancreatic cancer	0.000294	0.0169	CbGeAlD
Mefloquine—CYP2D6—digestive system—pancreatic cancer	0.000289	0.0167	CbGeAlD
Mefloquine—ABCB1—pancreas—pancreatic cancer	0.000243	0.014	CbGeAlD
Mefloquine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000222	0.000892	CcSEcCtD
Mefloquine—Mental disorder—Docetaxel—pancreatic cancer	0.000222	0.00089	CcSEcCtD
Mefloquine—Somnolence—Fluorouracil—pancreatic cancer	0.000221	0.000889	CcSEcCtD
Mefloquine—Malnutrition—Docetaxel—pancreatic cancer	0.00022	0.000885	CcSEcCtD
Mefloquine—Erythema—Docetaxel—pancreatic cancer	0.00022	0.000885	CcSEcCtD
Mefloquine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00022	0.000884	CcSEcCtD
Mefloquine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000219	0.00088	CcSEcCtD
Mefloquine—Nausea—Tamoxifen—pancreatic cancer	0.000219	0.000879	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000219	0.000878	CcSEcCtD
Mefloquine—Fatigue—Gemcitabine—pancreatic cancer	0.000218	0.000877	CcSEcCtD
Mefloquine—Muscular weakness—Epirubicin—pancreatic cancer	0.000218	0.000874	CcSEcCtD
Mefloquine—Nausea—Erlotinib—pancreatic cancer	0.000217	0.00087	CcSEcCtD
Mefloquine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000217	0.000869	CcSEcCtD
Mefloquine—Mood swings—Doxorubicin—pancreatic cancer	0.000216	0.000868	CcSEcCtD
Mefloquine—Diarrhoea—Sunitinib—pancreatic cancer	0.000216	0.000867	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000215	0.000864	CcSEcCtD
Mefloquine—Ataxia—Doxorubicin—pancreatic cancer	0.000215	0.000862	CcSEcCtD
Mefloquine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000214	0.000861	CcSEcCtD
Mefloquine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000213	0.000854	CcSEcCtD
Mefloquine—Muscle spasms—Docetaxel—pancreatic cancer	0.000212	0.00085	CcSEcCtD
Mefloquine—Dizziness—Sunitinib—pancreatic cancer	0.000209	0.000838	CcSEcCtD
Mefloquine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000209	0.000838	CcSEcCtD
Mefloquine—ABCB1—digestive system—pancreatic cancer	0.000208	0.012	CbGeAlD
Mefloquine—Abdominal pain—Irinotecan—pancreatic cancer	0.000206	0.000826	CcSEcCtD
Mefloquine—Body temperature increased—Irinotecan—pancreatic cancer	0.000206	0.000826	CcSEcCtD
Mefloquine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000205	0.000824	CcSEcCtD
Mefloquine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000201	0.000808	CcSEcCtD
Mefloquine—Vomiting—Sunitinib—pancreatic cancer	0.000201	0.000806	CcSEcCtD
Mefloquine—Body temperature increased—Gemcitabine—pancreatic cancer	0.0002	0.000804	CcSEcCtD
Mefloquine—Rash—Sunitinib—pancreatic cancer	0.000199	0.000799	CcSEcCtD
Mefloquine—Dermatitis—Sunitinib—pancreatic cancer	0.000199	0.000799	CcSEcCtD
Mefloquine—Urticaria—Fluorouracil—pancreatic cancer	0.000198	0.000795	CcSEcCtD
Mefloquine—Headache—Sunitinib—pancreatic cancer	0.000198	0.000794	CcSEcCtD
Mefloquine—Syncope—Docetaxel—pancreatic cancer	0.000198	0.000793	CcSEcCtD
Mefloquine—Leukopenia—Docetaxel—pancreatic cancer	0.000197	0.000792	CcSEcCtD
Mefloquine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000197	0.000791	CcSEcCtD
Mefloquine—Palpitations—Docetaxel—pancreatic cancer	0.000195	0.000782	CcSEcCtD
Mefloquine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000194	0.000777	CcSEcCtD
Mefloquine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000192	0.000769	CcSEcCtD
Mefloquine—Pneumonia—Epirubicin—pancreatic cancer	0.000191	0.000768	CcSEcCtD
Mefloquine—Convulsion—Docetaxel—pancreatic cancer	0.000191	0.000766	CcSEcCtD
Mefloquine—Hypertension—Docetaxel—pancreatic cancer	0.00019	0.000764	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000189	0.000757	CcSEcCtD
Mefloquine—Chest pain—Docetaxel—pancreatic cancer	0.000188	0.000753	CcSEcCtD
Mefloquine—Myalgia—Docetaxel—pancreatic cancer	0.000188	0.000753	CcSEcCtD
Mefloquine—Arthralgia—Docetaxel—pancreatic cancer	0.000188	0.000753	CcSEcCtD
Mefloquine—Nausea—Sunitinib—pancreatic cancer	0.000188	0.000753	CcSEcCtD
Mefloquine—Renal failure—Epirubicin—pancreatic cancer	0.000187	0.00075	CcSEcCtD
Mefloquine—Asthenia—Irinotecan—pancreatic cancer	0.000187	0.000749	CcSEcCtD
Mefloquine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000186	0.000748	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000186	0.000748	CcSEcCtD
Mefloquine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000184	0.000737	CcSEcCtD
Mefloquine—Sweating—Epirubicin—pancreatic cancer	0.000182	0.000732	CcSEcCtD
Mefloquine—Asthenia—Gemcitabine—pancreatic cancer	0.000182	0.00073	CcSEcCtD
Mefloquine—Confusional state—Docetaxel—pancreatic cancer	0.000181	0.000728	CcSEcCtD
Mefloquine—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00018	0.000722	CcSEcCtD
Mefloquine—Oedema—Docetaxel—pancreatic cancer	0.00018	0.000722	CcSEcCtD
Mefloquine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00018	0.000722	CcSEcCtD
Mefloquine—Pruritus—Gemcitabine—pancreatic cancer	0.000179	0.00072	CcSEcCtD
Mefloquine—Diarrhoea—Irinotecan—pancreatic cancer	0.000178	0.000715	CcSEcCtD
Mefloquine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000177	0.000712	CcSEcCtD
Mefloquine—Pneumonia—Doxorubicin—pancreatic cancer	0.000177	0.000711	CcSEcCtD
Mefloquine—Shock—Docetaxel—pancreatic cancer	0.000177	0.00071	CcSEcCtD
Mefloquine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000176	0.000708	CcSEcCtD
Mefloquine—Pruritus—Fluorouracil—pancreatic cancer	0.000176	0.000708	CcSEcCtD
Mefloquine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000176	0.000707	CcSEcCtD
Mefloquine—Tachycardia—Docetaxel—pancreatic cancer	0.000176	0.000705	CcSEcCtD
Mefloquine—Skin disorder—Docetaxel—pancreatic cancer	0.000175	0.000701	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000174	0.0007	CcSEcCtD
Mefloquine—Bradycardia—Epirubicin—pancreatic cancer	0.000174	0.000698	CcSEcCtD
Mefloquine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000173	0.000696	CcSEcCtD
Mefloquine—Renal failure—Doxorubicin—pancreatic cancer	0.000173	0.000694	CcSEcCtD
Mefloquine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000172	0.000692	CcSEcCtD
Mefloquine—Dizziness—Irinotecan—pancreatic cancer	0.000172	0.000691	CcSEcCtD
Mefloquine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00017	0.000684	CcSEcCtD
Mefloquine—Sweating—Doxorubicin—pancreatic cancer	0.000169	0.000677	CcSEcCtD
Mefloquine—Hypotension—Docetaxel—pancreatic cancer	0.000168	0.000675	CcSEcCtD
Mefloquine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000168	0.000674	CcSEcCtD
Mefloquine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000166	0.000668	CcSEcCtD
Mefloquine—Vomiting—Irinotecan—pancreatic cancer	0.000165	0.000664	CcSEcCtD
Mefloquine—Dizziness—Fluorouracil—pancreatic cancer	0.000165	0.000661	CcSEcCtD
Mefloquine—Visual impairment—Epirubicin—pancreatic cancer	0.000165	0.00066	CcSEcCtD
Mefloquine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000164	0.000659	CcSEcCtD
Mefloquine—Rash—Irinotecan—pancreatic cancer	0.000164	0.000658	CcSEcCtD
Mefloquine—Dermatitis—Irinotecan—pancreatic cancer	0.000164	0.000658	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000164	0.000658	CcSEcCtD
Mefloquine—Headache—Irinotecan—pancreatic cancer	0.000163	0.000654	CcSEcCtD
Mefloquine—Insomnia—Docetaxel—pancreatic cancer	0.000163	0.000653	CcSEcCtD
Mefloquine—Paraesthesia—Docetaxel—pancreatic cancer	0.000161	0.000648	CcSEcCtD
Mefloquine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000161	0.000648	CcSEcCtD
Mefloquine—Vomiting—Gemcitabine—pancreatic cancer	0.000161	0.000647	CcSEcCtD
Mefloquine—Bradycardia—Doxorubicin—pancreatic cancer	0.000161	0.000646	CcSEcCtD
Mefloquine—Dyspnoea—Docetaxel—pancreatic cancer	0.00016	0.000644	CcSEcCtD
Mefloquine—Somnolence—Docetaxel—pancreatic cancer	0.00016	0.000642	CcSEcCtD
Mefloquine—Rash—Gemcitabine—pancreatic cancer	0.00016	0.000641	CcSEcCtD
Mefloquine—Dermatitis—Gemcitabine—pancreatic cancer	0.00016	0.000641	CcSEcCtD
Mefloquine—Eye disorder—Epirubicin—pancreatic cancer	0.00016	0.000641	CcSEcCtD
Mefloquine—Tinnitus—Epirubicin—pancreatic cancer	0.000159	0.000639	CcSEcCtD
Mefloquine—Headache—Gemcitabine—pancreatic cancer	0.000159	0.000637	CcSEcCtD
Mefloquine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000158	0.000636	CcSEcCtD
Mefloquine—Flushing—Epirubicin—pancreatic cancer	0.000158	0.000636	CcSEcCtD
Mefloquine—Vomiting—Fluorouracil—pancreatic cancer	0.000158	0.000636	CcSEcCtD
Mefloquine—Dyspepsia—Docetaxel—pancreatic cancer	0.000158	0.000635	CcSEcCtD
Mefloquine—Rash—Fluorouracil—pancreatic cancer	0.000157	0.000631	CcSEcCtD
Mefloquine—Dermatitis—Fluorouracil—pancreatic cancer	0.000157	0.00063	CcSEcCtD
Mefloquine—Decreased appetite—Docetaxel—pancreatic cancer	0.000156	0.000628	CcSEcCtD
Mefloquine—Headache—Fluorouracil—pancreatic cancer	0.000156	0.000627	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000155	0.000623	CcSEcCtD
Mefloquine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000155	0.000623	CcSEcCtD
Mefloquine—Fatigue—Docetaxel—pancreatic cancer	0.000155	0.000622	CcSEcCtD
Mefloquine—Angiopathy—Epirubicin—pancreatic cancer	0.000155	0.000622	CcSEcCtD
Mefloquine—Nausea—Irinotecan—pancreatic cancer	0.000155	0.00062	CcSEcCtD
Mefloquine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000154	0.000618	CcSEcCtD
Mefloquine—Chills—Epirubicin—pancreatic cancer	0.000153	0.000615	CcSEcCtD
Mefloquine—Visual impairment—Doxorubicin—pancreatic cancer	0.000152	0.000611	CcSEcCtD
Mefloquine—Alopecia—Epirubicin—pancreatic cancer	0.000151	0.000606	CcSEcCtD
Mefloquine—Nausea—Gemcitabine—pancreatic cancer	0.000151	0.000604	CcSEcCtD
Mefloquine—Mental disorder—Epirubicin—pancreatic cancer	0.00015	0.0006	CcSEcCtD
Mefloquine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000149	0.0006	CcSEcCtD
Mefloquine—Malnutrition—Epirubicin—pancreatic cancer	0.000149	0.000597	CcSEcCtD
Mefloquine—Erythema—Epirubicin—pancreatic cancer	0.000149	0.000597	CcSEcCtD
Mefloquine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000148	0.000595	CcSEcCtD
Mefloquine—Nausea—Fluorouracil—pancreatic cancer	0.000148	0.000594	CcSEcCtD
Mefloquine—Eye disorder—Doxorubicin—pancreatic cancer	0.000148	0.000593	CcSEcCtD
Mefloquine—Tinnitus—Doxorubicin—pancreatic cancer	0.000147	0.000591	CcSEcCtD
Mefloquine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000147	0.00059	CcSEcCtD
Mefloquine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000147	0.000589	CcSEcCtD
Mefloquine—Flushing—Doxorubicin—pancreatic cancer	0.000147	0.000589	CcSEcCtD
Mefloquine—Angiopathy—Doxorubicin—pancreatic cancer	0.000143	0.000575	CcSEcCtD
Mefloquine—Muscle spasms—Epirubicin—pancreatic cancer	0.000143	0.000574	CcSEcCtD
Mefloquine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000142	0.000572	CcSEcCtD
Mefloquine—Body temperature increased—Docetaxel—pancreatic cancer	0.000142	0.000571	CcSEcCtD
Mefloquine—Abdominal pain—Docetaxel—pancreatic cancer	0.000142	0.000571	CcSEcCtD
Mefloquine—Chills—Doxorubicin—pancreatic cancer	0.000142	0.000569	CcSEcCtD
Mefloquine—Vision blurred—Epirubicin—pancreatic cancer	0.00014	0.000562	CcSEcCtD
Mefloquine—Alopecia—Doxorubicin—pancreatic cancer	0.00014	0.00056	CcSEcCtD
Mefloquine—Mental disorder—Doxorubicin—pancreatic cancer	0.000138	0.000556	CcSEcCtD
Mefloquine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000138	0.000554	CcSEcCtD
Mefloquine—Erythema—Doxorubicin—pancreatic cancer	0.000138	0.000552	CcSEcCtD
Mefloquine—Malnutrition—Doxorubicin—pancreatic cancer	0.000138	0.000552	CcSEcCtD
Mefloquine—Agitation—Epirubicin—pancreatic cancer	0.000137	0.000548	CcSEcCtD
Mefloquine—Malaise—Epirubicin—pancreatic cancer	0.000134	0.000538	CcSEcCtD
Mefloquine—Vertigo—Epirubicin—pancreatic cancer	0.000134	0.000536	CcSEcCtD
Mefloquine—Syncope—Epirubicin—pancreatic cancer	0.000133	0.000535	CcSEcCtD
Mefloquine—Leukopenia—Epirubicin—pancreatic cancer	0.000133	0.000534	CcSEcCtD
Mefloquine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000132	0.000532	CcSEcCtD
Mefloquine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000132	0.000531	CcSEcCtD
Mefloquine—Palpitations—Epirubicin—pancreatic cancer	0.000131	0.000527	CcSEcCtD
Mefloquine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000131	0.000524	CcSEcCtD
Mefloquine—Vision blurred—Doxorubicin—pancreatic cancer	0.00013	0.00052	CcSEcCtD
Mefloquine—Asthenia—Docetaxel—pancreatic cancer	0.000129	0.000518	CcSEcCtD
Mefloquine—Convulsion—Epirubicin—pancreatic cancer	0.000129	0.000517	CcSEcCtD
Mefloquine—Hypertension—Epirubicin—pancreatic cancer	0.000128	0.000515	CcSEcCtD
Mefloquine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000128	0.000512	CcSEcCtD
Mefloquine—Pruritus—Docetaxel—pancreatic cancer	0.000127	0.000511	CcSEcCtD
Mefloquine—Chest pain—Epirubicin—pancreatic cancer	0.000127	0.000508	CcSEcCtD
Mefloquine—Myalgia—Epirubicin—pancreatic cancer	0.000127	0.000508	CcSEcCtD
Mefloquine—Arthralgia—Epirubicin—pancreatic cancer	0.000127	0.000508	CcSEcCtD
Mefloquine—Agitation—Doxorubicin—pancreatic cancer	0.000126	0.000507	CcSEcCtD
Mefloquine—Anxiety—Epirubicin—pancreatic cancer	0.000126	0.000506	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000126	0.000504	CcSEcCtD
Mefloquine—Discomfort—Epirubicin—pancreatic cancer	0.000125	0.000502	CcSEcCtD
Mefloquine—Malaise—Doxorubicin—pancreatic cancer	0.000124	0.000498	CcSEcCtD
Mefloquine—Vertigo—Doxorubicin—pancreatic cancer	0.000124	0.000496	CcSEcCtD
Mefloquine—Syncope—Doxorubicin—pancreatic cancer	0.000123	0.000495	CcSEcCtD
Mefloquine—Leukopenia—Doxorubicin—pancreatic cancer	0.000123	0.000494	CcSEcCtD
Mefloquine—Diarrhoea—Docetaxel—pancreatic cancer	0.000123	0.000494	CcSEcCtD
Mefloquine—Confusional state—Epirubicin—pancreatic cancer	0.000122	0.000491	CcSEcCtD
Mefloquine—Palpitations—Doxorubicin—pancreatic cancer	0.000122	0.000488	CcSEcCtD
Mefloquine—Oedema—Epirubicin—pancreatic cancer	0.000121	0.000487	CcSEcCtD
Mefloquine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000121	0.000487	CcSEcCtD
Mefloquine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000121	0.000485	CcSEcCtD
Mefloquine—Shock—Epirubicin—pancreatic cancer	0.000119	0.000479	CcSEcCtD
Mefloquine—Convulsion—Doxorubicin—pancreatic cancer	0.000119	0.000478	CcSEcCtD
Mefloquine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000119	0.000478	CcSEcCtD
Mefloquine—Dizziness—Docetaxel—pancreatic cancer	0.000119	0.000477	CcSEcCtD
Mefloquine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000119	0.000477	CcSEcCtD
Mefloquine—Hypertension—Doxorubicin—pancreatic cancer	0.000119	0.000477	CcSEcCtD
Mefloquine—Tachycardia—Epirubicin—pancreatic cancer	0.000118	0.000475	CcSEcCtD
Mefloquine—Skin disorder—Epirubicin—pancreatic cancer	0.000118	0.000473	CcSEcCtD
Mefloquine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000117	0.000471	CcSEcCtD
Mefloquine—Arthralgia—Doxorubicin—pancreatic cancer	0.000117	0.00047	CcSEcCtD
Mefloquine—Chest pain—Doxorubicin—pancreatic cancer	0.000117	0.00047	CcSEcCtD
Mefloquine—Myalgia—Doxorubicin—pancreatic cancer	0.000117	0.00047	CcSEcCtD
Mefloquine—Anxiety—Doxorubicin—pancreatic cancer	0.000117	0.000468	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000116	0.000467	CcSEcCtD
Mefloquine—Discomfort—Doxorubicin—pancreatic cancer	0.000116	0.000464	CcSEcCtD
Mefloquine—Vomiting—Docetaxel—pancreatic cancer	0.000114	0.000459	CcSEcCtD
Mefloquine—Rash—Docetaxel—pancreatic cancer	0.000113	0.000455	CcSEcCtD
Mefloquine—Hypotension—Epirubicin—pancreatic cancer	0.000113	0.000455	CcSEcCtD
Mefloquine—Dermatitis—Docetaxel—pancreatic cancer	0.000113	0.000455	CcSEcCtD
Mefloquine—Confusional state—Doxorubicin—pancreatic cancer	0.000113	0.000454	CcSEcCtD
Mefloquine—Headache—Docetaxel—pancreatic cancer	0.000113	0.000452	CcSEcCtD
Mefloquine—Oedema—Doxorubicin—pancreatic cancer	0.000112	0.000451	CcSEcCtD
Mefloquine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000112	0.000451	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000111	0.000444	CcSEcCtD
Mefloquine—Shock—Doxorubicin—pancreatic cancer	0.00011	0.000443	CcSEcCtD
Mefloquine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00011	0.000442	CcSEcCtD
Mefloquine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00011	0.000441	CcSEcCtD
Mefloquine—Insomnia—Epirubicin—pancreatic cancer	0.00011	0.00044	CcSEcCtD
Mefloquine—Tachycardia—Doxorubicin—pancreatic cancer	0.00011	0.00044	CcSEcCtD
Mefloquine—Skin disorder—Doxorubicin—pancreatic cancer	0.000109	0.000438	CcSEcCtD
Mefloquine—Paraesthesia—Epirubicin—pancreatic cancer	0.000109	0.000437	CcSEcCtD
Mefloquine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000108	0.000436	CcSEcCtD
Mefloquine—Dyspnoea—Epirubicin—pancreatic cancer	0.000108	0.000434	CcSEcCtD
Mefloquine—Somnolence—Epirubicin—pancreatic cancer	0.000108	0.000433	CcSEcCtD
Mefloquine—Nausea—Docetaxel—pancreatic cancer	0.000107	0.000429	CcSEcCtD
Mefloquine—Dyspepsia—Epirubicin—pancreatic cancer	0.000107	0.000429	CcSEcCtD
Mefloquine—Decreased appetite—Epirubicin—pancreatic cancer	0.000105	0.000423	CcSEcCtD
Mefloquine—Hypotension—Doxorubicin—pancreatic cancer	0.000105	0.000421	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000105	0.00042	CcSEcCtD
Mefloquine—Fatigue—Epirubicin—pancreatic cancer	0.000105	0.00042	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000102	0.00041	CcSEcCtD
Mefloquine—Insomnia—Doxorubicin—pancreatic cancer	0.000102	0.000408	CcSEcCtD
Mefloquine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000101	0.000405	CcSEcCtD
Mefloquine—Dyspnoea—Doxorubicin—pancreatic cancer	0.0001	0.000402	CcSEcCtD
Mefloquine—Feeling abnormal—Epirubicin—pancreatic cancer	0.0001	0.000401	CcSEcCtD
Mefloquine—Somnolence—Doxorubicin—pancreatic cancer	9.98e-05	0.000401	CcSEcCtD
Mefloquine—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.92e-05	0.000398	CcSEcCtD
Mefloquine—Dyspepsia—Doxorubicin—pancreatic cancer	9.88e-05	0.000397	CcSEcCtD
Mefloquine—Decreased appetite—Doxorubicin—pancreatic cancer	9.76e-05	0.000392	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	9.69e-05	0.000389	CcSEcCtD
Mefloquine—Fatigue—Doxorubicin—pancreatic cancer	9.68e-05	0.000388	CcSEcCtD
Mefloquine—Urticaria—Epirubicin—pancreatic cancer	9.64e-05	0.000387	CcSEcCtD
Mefloquine—Abdominal pain—Epirubicin—pancreatic cancer	9.59e-05	0.000385	CcSEcCtD
Mefloquine—Body temperature increased—Epirubicin—pancreatic cancer	9.59e-05	0.000385	CcSEcCtD
Mefloquine—Feeling abnormal—Doxorubicin—pancreatic cancer	9.25e-05	0.000371	CcSEcCtD
Mefloquine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.18e-05	0.000368	CcSEcCtD
Mefloquine—Hypersensitivity—Epirubicin—pancreatic cancer	8.94e-05	0.000359	CcSEcCtD
Mefloquine—Urticaria—Doxorubicin—pancreatic cancer	8.92e-05	0.000358	CcSEcCtD
Mefloquine—Abdominal pain—Doxorubicin—pancreatic cancer	8.87e-05	0.000356	CcSEcCtD
Mefloquine—Body temperature increased—Doxorubicin—pancreatic cancer	8.87e-05	0.000356	CcSEcCtD
Mefloquine—Asthenia—Epirubicin—pancreatic cancer	8.7e-05	0.000349	CcSEcCtD
Mefloquine—Pruritus—Epirubicin—pancreatic cancer	8.58e-05	0.000345	CcSEcCtD
Mefloquine—Diarrhoea—Epirubicin—pancreatic cancer	8.3e-05	0.000333	CcSEcCtD
Mefloquine—Hypersensitivity—Doxorubicin—pancreatic cancer	8.27e-05	0.000332	CcSEcCtD
Mefloquine—Asthenia—Doxorubicin—pancreatic cancer	8.05e-05	0.000323	CcSEcCtD
Mefloquine—Dizziness—Epirubicin—pancreatic cancer	8.02e-05	0.000322	CcSEcCtD
Mefloquine—Pruritus—Doxorubicin—pancreatic cancer	7.94e-05	0.000319	CcSEcCtD
Mefloquine—Vomiting—Epirubicin—pancreatic cancer	7.71e-05	0.00031	CcSEcCtD
Mefloquine—Diarrhoea—Doxorubicin—pancreatic cancer	7.68e-05	0.000308	CcSEcCtD
Mefloquine—Rash—Epirubicin—pancreatic cancer	7.65e-05	0.000307	CcSEcCtD
Mefloquine—Dermatitis—Epirubicin—pancreatic cancer	7.64e-05	0.000307	CcSEcCtD
Mefloquine—Headache—Epirubicin—pancreatic cancer	7.6e-05	0.000305	CcSEcCtD
Mefloquine—Dizziness—Doxorubicin—pancreatic cancer	7.42e-05	0.000298	CcSEcCtD
Mefloquine—Nausea—Epirubicin—pancreatic cancer	7.2e-05	0.000289	CcSEcCtD
Mefloquine—Vomiting—Doxorubicin—pancreatic cancer	7.14e-05	0.000286	CcSEcCtD
Mefloquine—Rash—Doxorubicin—pancreatic cancer	7.08e-05	0.000284	CcSEcCtD
Mefloquine—Dermatitis—Doxorubicin—pancreatic cancer	7.07e-05	0.000284	CcSEcCtD
Mefloquine—Headache—Doxorubicin—pancreatic cancer	7.03e-05	0.000282	CcSEcCtD
Mefloquine—Nausea—Doxorubicin—pancreatic cancer	6.67e-05	0.000268	CcSEcCtD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.84e-05	0.000421	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTHLH—pancreatic cancer	3.83e-05	0.00042	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTCH1—pancreatic cancer	3.83e-05	0.00042	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STK11—pancreatic cancer	3.81e-05	0.000417	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—DPYD—pancreatic cancer	3.78e-05	0.000414	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	3.74e-05	0.00041	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—HRAS—pancreatic cancer	3.73e-05	0.000409	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	3.7e-05	0.000406	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC2A2—pancreatic cancer	3.69e-05	0.000405	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.66e-05	0.000401	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.64e-05	0.000399	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC2A2—pancreatic cancer	3.59e-05	0.000393	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.58e-05	0.000392	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.55e-05	0.000389	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.54e-05	0.000388	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.53e-05	0.000387	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SST—pancreatic cancer	3.51e-05	0.000384	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.5e-05	0.000384	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.46e-05	0.000379	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.43e-05	0.000376	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—JAG1—pancreatic cancer	3.43e-05	0.000376	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.43e-05	0.000376	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH3—pancreatic cancer	3.42e-05	0.000375	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—AKT1—pancreatic cancer	3.36e-05	0.000369	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SMAD4—pancreatic cancer	3.33e-05	0.000365	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.3e-05	0.000362	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—AKT1—pancreatic cancer	3.3e-05	0.000361	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HES1—pancreatic cancer	3.25e-05	0.000357	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CNR1—pancreatic cancer	3.24e-05	0.000355	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.21e-05	0.000352	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.15e-05	0.000345	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.14e-05	0.000344	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—GCG—pancreatic cancer	3.12e-05	0.000343	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.12e-05	0.000342	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.12e-05	0.000342	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CD44—pancreatic cancer	3.11e-05	0.000341	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.07e-05	0.000336	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.05e-05	0.000334	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	3.05e-05	0.000334	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—HRAS—pancreatic cancer	3.04e-05	0.000333	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.04e-05	0.000333	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.02e-05	0.000331	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL8—pancreatic cancer	2.99e-05	0.000328	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GCG—pancreatic cancer	2.99e-05	0.000327	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AGTR1—pancreatic cancer	2.98e-05	0.000327	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STK11—pancreatic cancer	2.94e-05	0.000322	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.92e-05	0.000321	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.89e-05	0.000317	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CD44—pancreatic cancer	2.86e-05	0.000314	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TERT—pancreatic cancer	2.85e-05	0.000313	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.85e-05	0.000312	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.82e-05	0.000309	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—STK11—pancreatic cancer	2.81e-05	0.000308	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.8e-05	0.000307	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CD44—pancreatic cancer	2.78e-05	0.000305	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.78e-05	0.000304	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.76e-05	0.000303	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.75e-05	0.000301	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GCG—pancreatic cancer	2.74e-05	0.000301	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HIF1A—pancreatic cancer	2.73e-05	0.000299	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TSC2—pancreatic cancer	2.72e-05	0.000298	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.72e-05	0.000298	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	2.72e-05	0.000298	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—HRAS—pancreatic cancer	2.71e-05	0.000297	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.69e-05	0.000296	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GCG—pancreatic cancer	2.66e-05	0.000292	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—APOE—pancreatic cancer	2.66e-05	0.000292	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ARG2—pancreatic cancer	2.66e-05	0.000292	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.65e-05	0.000291	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.63e-05	0.000289	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KDR—pancreatic cancer	2.61e-05	0.000286	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—STK11—pancreatic cancer	2.58e-05	0.000283	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SMAD4—pancreatic cancer	2.57e-05	0.000282	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.55e-05	0.000279	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	2.55e-05	0.000279	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	2.53e-05	0.000278	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HES1—pancreatic cancer	2.51e-05	0.000276	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.51e-05	0.000275	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—STK11—pancreatic cancer	2.5e-05	0.000275	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKBIA—pancreatic cancer	2.48e-05	0.000272	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.48e-05	0.000272	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NOTCH1—pancreatic cancer	2.46e-05	0.000269	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.42e-05	0.000265	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—TYMS—pancreatic cancer	2.41e-05	0.000265	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.41e-05	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	2.4e-05	0.000263	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	2.4e-05	0.000263	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGF—pancreatic cancer	2.37e-05	0.00026	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.35e-05	0.000258	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.34e-05	0.000256	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TYMP—pancreatic cancer	2.33e-05	0.000255	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	2.31e-05	0.000254	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.28e-05	0.00025	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.28e-05	0.00025	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	2.26e-05	0.000248	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.23e-05	0.000245	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TYMS—pancreatic cancer	2.22e-05	0.000243	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	2.2e-05	0.000241	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.19e-05	0.00024	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	2.19e-05	0.00024	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TYMS—pancreatic cancer	2.15e-05	0.000236	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.13e-05	0.000233	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	2.11e-05	0.000232	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.11e-05	0.000231	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	2.11e-05	0.000231	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	2.1e-05	0.00023	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.09e-05	0.000229	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.08e-05	0.000228	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	2.07e-05	0.000227	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	2.06e-05	0.000225	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	2.01e-05	0.000221	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—APOE—pancreatic cancer	1.96e-05	0.000215	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.94e-05	0.000212	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	1.92e-05	0.00021	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.9e-05	0.000208	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	1.9e-05	0.000208	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.89e-05	0.000207	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GLP1R—pancreatic cancer	1.87e-05	0.000206	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.87e-05	0.000206	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.86e-05	0.000204	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	1.86e-05	0.000203	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	1.86e-05	0.000203	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—DPYD—pancreatic cancer	1.84e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	1.84e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	1.83e-05	0.000201	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—APOE—pancreatic cancer	1.8e-05	0.000198	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CG—pancreatic cancer	1.77e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	1.77e-05	0.000194	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.77e-05	0.000194	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	1.76e-05	0.000193	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—APOE—pancreatic cancer	1.75e-05	0.000192	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.75e-05	0.000192	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.74e-05	0.000191	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARG—pancreatic cancer	1.71e-05	0.000188	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	1.71e-05	0.000187	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.71e-05	0.000187	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	1.69e-05	0.000186	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	1.69e-05	0.000185	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.66e-05	0.000182	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.65e-05	0.000181	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	1.65e-05	0.000181	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.64e-05	0.00018	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	1.63e-05	0.000179	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	1.63e-05	0.000179	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CG—pancreatic cancer	1.63e-05	0.000179	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.62e-05	0.000177	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	1.6e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	1.6e-05	0.000175	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	1.59e-05	0.000174	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.58e-05	0.000174	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CG—pancreatic cancer	1.58e-05	0.000173	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARG—pancreatic cancer	1.57e-05	0.000172	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CD—pancreatic cancer	1.56e-05	0.000171	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	1.55e-05	0.00017	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARG—pancreatic cancer	1.53e-05	0.000167	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—SRC—pancreatic cancer	1.48e-05	0.000162	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.47e-05	0.000161	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	1.44e-05	0.000158	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.43e-05	0.000157	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CD—pancreatic cancer	1.43e-05	0.000157	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	1.42e-05	0.000156	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	1.42e-05	0.000156	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	1.42e-05	0.000156	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CD—pancreatic cancer	1.39e-05	0.000152	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	1.37e-05	0.00015	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CB—pancreatic cancer	1.36e-05	0.000149	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	1.36e-05	0.000149	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CD44—pancreatic cancer	1.36e-05	0.000149	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTGS2—pancreatic cancer	1.35e-05	0.000148	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—pancreatic cancer	1.32e-05	0.000145	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	1.32e-05	0.000145	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	1.32e-05	0.000145	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	1.31e-05	0.000143	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCG—pancreatic cancer	1.3e-05	0.000142	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	1.29e-05	0.000142	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.28e-05	0.00014	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	1.27e-05	0.00014	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	1.26e-05	0.000138	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CB—pancreatic cancer	1.25e-05	0.000137	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTGS2—pancreatic cancer	1.24e-05	0.000136	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	1.24e-05	0.000135	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	1.23e-05	0.000135	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.22e-05	0.000134	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—STK11—pancreatic cancer	1.22e-05	0.000134	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	1.22e-05	0.000134	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CB—pancreatic cancer	1.21e-05	0.000133	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTGS2—pancreatic cancer	1.2e-05	0.000132	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	1.2e-05	0.000131	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PTEN—pancreatic cancer	1.17e-05	0.000129	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.15e-05	0.000127	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.15e-05	0.000126	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	1.14e-05	0.000125	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.14e-05	0.000125	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	1.12e-05	0.000123	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	1.11e-05	0.000122	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	1.1e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	1.1e-05	0.00012	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	0.000119	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.08e-05	0.000118	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PTEN—pancreatic cancer	1.08e-05	0.000118	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.05e-05	0.000115	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PTEN—pancreatic cancer	1.05e-05	0.000115	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	1.04e-05	0.000114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	1.02e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	1.02e-05	0.000112	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	9.98e-06	0.000109	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TYMS—pancreatic cancer	9.9e-06	0.000109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	9.43e-06	0.000103	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	9.17e-06	0.000101	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	8.67e-06	9.5e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—APOE—pancreatic cancer	8.55e-06	9.37e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	8.38e-06	9.19e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CD44—pancreatic cancer	8.35e-06	9.16e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PIK3CA—pancreatic cancer	8.28e-06	9.08e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—APOE—pancreatic cancer	8.05e-06	8.83e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	8.02e-06	8.79e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCG—pancreatic cancer	8.01e-06	8.78e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	7.71e-06	8.46e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PIK3CA—pancreatic cancer	7.61e-06	8.34e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—STK11—pancreatic cancer	7.53e-06	8.25e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARG—pancreatic cancer	7.44e-06	8.16e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PIK3CA—pancreatic cancer	7.38e-06	8.1e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	7.27e-06	7.97e-05	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	7.08e-06	7.76e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARG—pancreatic cancer	7.01e-06	7.69e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.78e-06	7.44e-05	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AKT1—pancreatic cancer	6.76e-06	7.41e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.47e-06	7.1e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	6.39e-06	7.01e-05	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AKT1—pancreatic cancer	6.21e-06	6.81e-05	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AKT1—pancreatic cancer	6.03e-06	6.61e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.91e-06	6.48e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.86e-06	6.42e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.57e-06	6.11e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	5.52e-06	6.05e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—APOE—pancreatic cancer	5.27e-06	5.77e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PTEN—pancreatic cancer	5.11e-06	5.6e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.81e-06	5.28e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.75e-06	5.21e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.59e-06	5.03e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.18e-06	4.58e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.64e-06	3.99e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.61e-06	3.96e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.6e-06	3.95e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.39e-06	3.72e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.15e-06	3.45e-05	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.94e-06	3.23e-05	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.77e-06	3.04e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.22e-06	2.43e-05	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.81e-06	1.99e-05	CbGpPWpGaD
